13 completed. 13 Phase 2, 3 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Completed 13 |
| Phase 3 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 2 |
Follow Cabergoline: new trials by email Literature Review of Cabergoline trials Research Report on Cabergoline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cabergoline for Lactation Inhibition After Early Second-Trimester Abortion or Pregnancy Loss Cabergoline 1 MG, Placebo - Lactation Suppressed | Phase 2 | Completed | Stanford University | 69 | 2024-02-07 | 2025-10-03 |
| Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS Metformin Hydrochloride 500 MG, Cabergoline 0.5 MG, Metformin Hydrochloride 500 MG + Cabergoline 0.5 MG - Polycystic Ovary Syndrome | Phase 2 | Completed | Al-Rasheed University College | 75 | 2022-09-21 | 2023-08-08 |
| Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Loss Cabergoline 1 MG, Placebo - Lactation Suppressed | Phase 2 | Completed | Stanford University | 73 | 2021-04-01 | 2024-02-13 |
| Non-surgical Interventions for Infertility in Endometriosis Cabergoline plus timed intercourse, Dydrogesterone plus timed intercourse - Endometriosis, Infertility, Female | Phase 2 | Completed | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 18 | 2020-07-01 | 2024-08-19 |
| Cabergoline for the Treatment of Chronic Pain Due to Endometriosis Cabergoline 0.5 MG, Placebo - Cap - Endometriosis | Phase 2 | Completed | Boston Children's Hospital | 129 | 2019-12-02 | 2026-01-28 |
| Cabergoline Versus Calcium Gluconate Infusion in the Prevention of Ovarian Hyperstimulation Syndrome Cabergoline, Calcium gluconate - OHSS | Phase 2 | Completed | Aljazeera Hospital | 170 | 2016-10-01 | 2018-12-27 |
| Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study Cabergoline, Norethindrone acetate - Endometriosis | Phase 2 | Completed | Boston Children's Hospital | 10 | 2016-05-01 | 2020-02-05 |
| Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome Diosmin, Cabergoline - Infertility | Phase 2 / Phase 3 | Completed | Benha University | 200 | 2014-04-01 | 2016-02-02 |
| Calcium Dobesilate Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome Calcium Dobesilate, Cabergoline - Infertility | Phase 2 / Phase 3 | Completed | Benha University | 200 | 2014-04-01 | 2017-02-16 |
| Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas Pasireotide, cabergoline - Non-functioning Pituitary Adenomas, Prolactinomas | Phase 2 / Phase 3 | Completed | Universidade Federal do Rio de Janeiro | 21 | 2010-03-01 | 2016-08-22 |
| Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) Program Cabergoline, Control - Ovarian Hyperstimulation Syndrome | Phase 1 / Phase 2 | Completed | Royan Institute | 10 | 2009-06-01 | 2015-05-06 |
| Effect of Cabergoline on Weight and Glucose Tolerance Cabergoline, placebo - Body Weight, Impaired Glucose Tolerance in Obese | Phase 1 / Phase 2 | Completed | Columbia University | 40 | 2002-04-01 | 2015-10-14 |
| A Study of Cabergoline for the Treatment of Cocaine Dependence - 1 Cabergoline, Placebo - Cocaine-Related Disorders, Substance-Related Disorders | Phase 2 | Completed | National Institute on Drug Abuse (NIDA) | 140 | 2001-06-01 | 2017-01-12 |
Endometriosis (3) · Infertility (3) · Breast Feeding (2) · Hyperemia (2) · Body Weight (1) · Cocaine-Related Disorders (1) · Fetal Death (1) · Infertility, Female (1) · Ovarian Hyperstimulation Syndrome (1) · Polycystic Ovary Syndrome (1) · Prolactinoma (1) · Stillbirth (1) · Substance-Related Disorders (1)
Benha University (2) · Boston Children's Hospital (2) · Stanford University (2) · Al-Rasheed University College (1) · Aljazeera Hospital (1) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Columbia University (1) · National Institute on Drug Abuse (NIDA) (1) · Royan Institute (1) · Universidade Federal do Rio de Janeiro (1)
United States (6) · Egypt (3) · Bangladesh (1) · Brazil (1) · Iran (1) · Iraq (1)
Ashraf Moini, MD (1) · Eniseh Tehraninejad, MD (1) · Hayder Adnan Fawzi, Ph.D Clinical Pharmacy (1) · Inas Naser Hamad, B.Sc. Pharmacy (1) · Judith Korner, MD, PHD (1) · Marzieh Shiva, MD (1) · Shakeela Ishrat, FCPS Obgyn (1) · Sinaa Abdul Amir Kadhim, Ph.D Pharmacology (1) · Steve Shoptaw, Ph.D. (1) · Usama M Fouda, M.D,PhD (1)
PMID 22231013, PMID 33851429, PMID 34934987, PMID 37486652, PMID 37863161, PMID 41538804